Oral Busulfan and Cyclophosphamide (BU/CY) versus Cyclophosphamide, Melphalan and Vepsid (Etoposide) (CMV) with Autologous Stem Cell Transplant in Patients with Relapsed Non-Hodgkin Lymphomas (NHL)

Journal Title: International Blood Research & Reviews - Year 2017, Vol 7, Issue 4

Abstract

Background: High dose chemotherapy with autologous stem cell transplantation (ASCT) is the standard of care and commonly used procedure for patients with relapsed non Hodgkin lymphomas (NHL). There is no clear evidence of superior conditioning regimen and studies that comparing different high dose regimens regarding the efficacy and toxicity profiles were little. Objectives: To compare efficacy and toxicity profiles of BU/CY and CMV conditioning regimens in patients with relapsed NHL scheduled for ASCT. Patients and Methods: Between June 2013 and January 2017, a total of 50 patients were enrolled in the study, 25 patients received CMV and 25 patients received BU/CY followed by ASCT in Bone Marrow Transplantation Center, Nasser Institute and El Sheikh zayed Hospitals, Egypt. Results: The median time for both neutrophil and platelet engraftment showed no significant difference between the two groups (p= .4) and (p=.3) respectively. Transplant related mortality (TRM) was less in CMV arm, but p value didn't reach the statistical difference (p= .1). The 3- year DFS and OS were slightly higher in CMV arm. However, they didn't show any significant statistical difference 72.8% and 66.5%, (p =.81) and (p= .07). The toxicities, Grade III / IV mucositis, nausea/vomiting and diarrhea occurred slightly higher in BU/CY than in the CMV (16%, 24%, 8% vs. 12%, 16%, 4% respectively).Pulmonary toxicity was higher in BU/CY (3 patients (12%) in BU/CY arm and 1 patient (4%) in CMV arm). However, the toxicities didn't reach the statistical difference. Conclusion: We found that both BU/CY and CMV regimens are not significantly different in terms of efficacy and toxicity. Although, the small number of patients that were enrolled in our study, we recommend further trial with larger number of patients to confirm the results.

Authors and Affiliations

Ashraf Zedan, Raafat Abd EL Fattah, Abeer Ibrahim, Ahmed Mubarak

Keywords

Related Articles

Suitability of Lower K2 EDTA Sample Volumes for Absolute CD4 Count Enumeration by Flow Cytometric Technique

Background: Incorrect blood sample volume-anticoagulant ratio has been the cause of both haematological and immunological errors especially when K3 EDTA-containing blood collection tubes were used. Lower whole blood samp...

Hematological Changes Following Oral Administration of Aqueous Root Bark Extract of Salacia lehmbachii in Albino Rats

Objective: This study investigated the effects of oral administration of aqueous root bark extract of Salacia lehmbachii on some haematological indices in albino rats. Methodology: Twenty-four male rats weighing 180-200...

Haematologic Profile of Patients with Chronic Kidney Disease in Port Harcourt, South-South Nigeria

Aim: The objective of this study is to assess the haematological profile of our patients with chronic kidney disease. Study Design: This was a cross-sectional case-control study. Place and Duration of Study: University...

Iron Deficiency and Iron Deficiency Anemia in Adolescent Girls in Rural Upper Egypt

Background: Iron deficiency (ID) and iron deficiency anemia (IDA) in adolescents tends to increase with age due to acceleration of growth. Objectives: This study aimed to determine the prevalence of ID and IDA in adoles...

Prevalence of Some Hematological Abnormalities among HIV Positive Patients on Their First Visit to a Tertiary Health Institution in Ethiopia; A Cross Sectional Study

Aim: The main objective of this study was to identify the magnitude of hematological abnormalities among HIV patients on their first visit to antiretroviral treatment (ART) centers. Methods: A cross sectional study was...

Download PDF file
  • EP ID EP306734
  • DOI 10.9734/IBRR/2017/35556
  • Views 139
  • Downloads 0

How To Cite

Ashraf Zedan, Raafat Abd EL Fattah, Abeer Ibrahim, Ahmed Mubarak (2017). Oral Busulfan and Cyclophosphamide (BU/CY) versus Cyclophosphamide, Melphalan and Vepsid (Etoposide) (CMV) with Autologous Stem Cell Transplant in Patients with Relapsed Non-Hodgkin Lymphomas (NHL). International Blood Research & Reviews, 7(4), 1-10. https://www.europub.co.uk/articles/-A-306734